B.1.1.7 variant
ConceptMentioned in 1 video
COVID-19 variant prevalent in the US, with a single amino acid substitution increasing binding affinity to ACE2, but still effectively neutralized by current vaccines.
COVID-19 variant prevalent in the US, with a single amino acid substitution increasing binding affinity to ACE2, but still effectively neutralized by current vaccines.